CLOs on the Move

Indiana Hemophilia and Thrombosis Center

www.ihtc.org

 
The Indiana Hemophilia & Thrombosis Center (IHTC) is the only federally recognized comprehensive hemophilia treatment center in Indiana and one of the largest centers in the nation. The IHTC is a 501(c)3 nonprofit entity that is dedicated to providing the best, most comprehensive care to people in Indiana with bleeding or clotting disorders and to their families. The IHTC is both nationally and internationally distinguished as a Center of Excellence for its leadership in bleeding disorder patient care, education and research.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ihtc.org
  • 8326 Naab Road
    Indianapolis, IN USA 46260
  • Phone: 317.871.0000

Executives

Name Title Contact Details

Similar Companies

Cummins, MacFail and Nutry

Cummins, MacFail & Nutry is a Somerville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accelovance Inc.

Accelovance Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Rockville, MD. To find more information about Accelovance Inc., please visit www.accelovance.com

RoundGlass

RoundGlass is committed to enabling individuals to live their Journey of holistic Wellbeing and Meaningful Living™. The RoundGlass community of associates, portfolio companies, fellows, partners and ambassadors advocate and develop solutions across the RoundGlass holistic Wellbeing Pillars. The RoundGlass Wholistic Wellbeing Pillars: 1. Live – Wellbeing of self: From the right health care decision to celebrating life 2. Learn – Wellbeing of the future: Living with purpose and mastering key qualities 3. Give – Wellbeing of society: Empowering community wellbeing so that all members live with dignity 4. Sustain – Wellbeing of the planet: Meaningful programs that improve the environment

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.

VaxInnate Corporation

VaxInnate Corporation is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Cranbury, NJ. To find more information about VaxInnate Corporation, please visit www.vaxinnate.com